AcademicCME Podcast
By Patrick Hayes
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Patrick Hayes
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 60
Description
Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice
| Episode | Date |
|---|---|
|
プライマリ・ケアにおける難治性高血圧管理の改善
|
May 05, 2026 |
|
Mejora del manejo de la hipertensión de difícil control en Atención primaria
|
May 05, 2026 |
|
Updating the Efficacy and Safety Experience of IL-17 Inhibitors
|
Jan 22, 2026 |
|
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies
|
Dec 11, 2025 |
|
Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD
|
Dec 11, 2025 |
|
Therapeutic Update on COPD with Type 2 Inflammation
|
Nov 25, 2025 |
|
Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making
|
Nov 24, 2025 |
|
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
|
Nov 17, 2025 |
|
ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering
|
Nov 17, 2025 |
|
Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)
|
Oct 28, 2025 |
|
Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function
|
Oct 28, 2025 |
|
Conference Review and Analysis of Relevant Data Pertaining to LDL-C
|
Oct 28, 2025 |
|
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia
|
Aug 21, 2025 |
|
Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis
|
Jul 31, 2025 |
|
Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists
|
Jul 18, 2025 |
|
ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
|
Jul 16, 2025 |
|
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
|
Mar 17, 2025 |
|
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
|
Mar 17, 2025 |
|
Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD
|
Dec 03, 2024 |
|
DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria
|
Nov 21, 2024 |
|
PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy
|
Nov 05, 2024 |
|
Clinical Trial Data Review for PBC Therapeutics
|
Oct 17, 2024 |
|
PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease
|
Oct 16, 2024 |
|
A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center
|
Aug 06, 2024 |
|
IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment
|
Jun 19, 2024 |
|
VTE and Anticoagulation - Guideline Updates for 2024
|
Apr 25, 2024 |
|
Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE
|
Mar 26, 2024 |
|
Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE
|
Jan 10, 2024 |
|
Part 1: Advances in Patient-Actuated Treatment for PSVT
|
Aug 16, 2023 |
|
Part 2: Advances in Patient-Actuated Treatment for PSVT
|
Aug 16, 2023 |
|
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer
|
Jan 09, 2023 |
|
Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies
|
Jan 03, 2023 |
|
Hyperkalemia 3: Clinical Trial Update for Newer Therapeutic Options to Treat Hyperkalemia
|
Jan 03, 2023 |
|
Hyperkalemia Part 2: Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia
|
Jan 03, 2023 |
|
Hyperkalemia Part 1: Review the Science of Recurrent Hyperkalemia, Including Relationships Between Dietary Potassium Intake, Serum Potassium, and Patient Morbidities
|
Jan 03, 2023 |
|
Avances en el tratamiento de la ERC con inhibidores de SGLT2 en pacientes con y sin diabetes: el ensayo EMPA-KIDNEY
|
Dec 27, 2022 |
|
Kombinationstherapie der chronischen Nierenerkrankung: Die EMPA-Kidney Studie
|
Dec 22, 2022 |
|
EMPA-Kidney: la révolution de la néphroprotection par les inhibiteurs SGLT-2 est là
|
Dec 21, 2022 |
|
Advances in Slowing the Progression of CKD with SGLT2 Inhibitors
|
Dec 15, 2022 |
|
NTM Series Ep. 5: Evaluation of Clinical Data on NTM‐LD Therapeutics and Management
|
Dec 13, 2022 |
|
NTM Series Ep. 4: Diagnostic Stratgies and Long-Term Management of Patients with NTM-LD
|
Nov 22, 2022 |
|
NTM Series Ep. 3: Clinical Trial Update: ATS 2022
|
Sep 29, 2022 |
|
NTM Series Ep. 2: Improving Adherence and Outcomes While Reducing the Risk of Drug-Related Toxicity
|
Aug 03, 2022 |
|
NTM Series Ep. 1: Adapting Treatment Goals Based on Patient Needs
|
Jul 21, 2022 |
|
Part 2: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies
|
Jun 17, 2022 |
|
Part 1: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies
|
Mar 08, 2022 |
|
Advances in Fumarate-based Therapeutics to Improve Outcomes in Patients with Multiple Sclerosis
|
Oct 05, 2021 |
|
Clinical Trial Update: MSVirtual 2020 (Multiple Sclerosis Podcast Series EP. 1)
|
Oct 22, 2020 |
|
Alzheimer’s Education for Patients and Care Givers: Strategies for Shared-Decision Making (Alzheimer's Disease Podcast Series Ep. 6)
|
Oct 15, 2020 |
|
Advances in Neuroimaging and Technology for AD Detection and Management (Alzheimer's Disease Podcast Series Ep. 5)
|
Oct 15, 2020 |
|
The Role of Genetics and Mechanisms of Synaptic Dysfunction (Alzheimer's Disease Podcast Series Ep. 4)
|
Oct 15, 2020 |
|
Early Diagnosis and Biomarkers in Alzheimer’s Disease (Alzheimer’s Disease Podcast Series Ep. 3)
|
Oct 15, 2020 |
|
Clinical Trial Data Review & Analyses: AAIC 2020 (Alzheimer's Disease Podcast Series Ep. 2)
|
Oct 15, 2020 |
|
Virtual Healthcare for Patients with AD During COVID-19 Pandemic (Alzheimer's Disease Podcast Series Ep.1)
|
Oct 15, 2020 |
|
Educating Your Patients: Approaches for Shared-Decision Making (Multiple Sclerosis Podcast Series Ep. 6)
|
Oct 13, 2020 |
|
Advances in MS Biomarkers and MRI Imaging to Monitor Disease Activity (Multiple Sclerosis Podcast Series Ep. 5)
|
Oct 13, 2020 |
|
A New Approach to Therapeutic Targets: Innate Immunity and the CNS (Multiple Sclerosis Podcast Series Ep. 4)
|
Oct 13, 2020 |
|
Updates in Multiple Sclerosis Science and Accurate Diagnosis (Multiple Sclerosis Podcast Series Ep.3)
|
Oct 13, 2020 |
|
Caring for the MS Patient During the COVID-19 Pandemic (Multiple Sclerosis Podcast Series Ep. 2)
|
Oct 13, 2020 |
|
An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes
|
May 08, 2020 |